Research summary

Collagen and Bone Density

Key takeaway

A 12-month randomized controlled trial in postmenopausal women reported that about 5 g/day of specific collagen peptides was associated with increased bone mineral density at the spine and femoral neck versus placebo, alongside a favorable shift in bone turnover markers. A 2025 systematic review and meta-analysis of randomized trials reached a broadly similar conclusion but noted high variation between studies. Overall the evidence is suggestive rather than definitive, and effects may not apply to all people, doses, or products.[1], [2]

What the randomized trial measured

A double-blind, placebo-controlled randomized trial enrolled 131 postmenopausal women with primary, age-related reduction in bone mineral density and gave them either about 5 g/day of specific collagen peptides or placebo for 12 months. Compared with placebo, the collagen group showed a significant increase in bone mineral density at both the spine and the femoral neck over the study period.[1], [2]

The trial also tracked blood markers of bone metabolism. The bone-formation marker increased in the collagen group, while a marker of bone breakdown increased in the placebo group, a pattern the authors interpreted as a shift toward bone formation. These findings describe what was observed at a single dose over one year and should not be read as a treatment recommendation.[1], [2]

What the pooled evidence suggests

A 2025 systematic review and meta-analysis pooled randomized trials of collagen peptide supplementation, taken alone or together with calcium and vitamin D. It reported that collagen peptide intake was associated with higher bone mineral density at the femoral neck and spine, and with improvements in bone turnover markers, with apparent additional benefit when collagen was combined with calcium and vitamin D.[1], [2]

How strong is the evidence

The current human evidence rests mainly on a single 12-month randomized trial and a meta-analysis that itself reported substantial variation between the studies it combined. That heterogeneity means the true size and consistency of any effect on bone mineral density remain uncertain, and results may not generalize across different populations, doses, or specific collagen products.[1], [2]

Limitations

The randomized evidence is limited in quantity and duration, and the supporting meta-analysis reported high statistical heterogeneity (I2 = 80.1%) across trials, so confidence in a consistent benefit is modest. Much of the favorable data involve collagen taken alongside calcium and vitamin D, making it difficult to isolate collagen's independent contribution.[1], [2]

Findings come from specific populations, most clearly postmenopausal women with reduced bone mineral density, and from a particular dose of around 5 g/day; they may not extend to other groups, doses, or formulations. This summary is informational and is not medical advice.[1], [2]

References

  1. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study.. Nutrients. 2018. Randomized controlled trial View source →
  2. Efficacy of collagen peptide supplementation on bone and muscle health: a meta-analysis.. Frontiers in nutrition. 2025. Systematic review View source →
Foundational guide

What is collagen?

Read the guide →